Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative

Data are presented on patterns of failure and delay in making initial treatment contact after first onset of a mental disorder in 15 countries in the World Health Organization (WHO)''s World Mental Health (WMH) Surveys. Representative face-to-face household surveys were conducted among 76,012 respondents aged 18 and older in Belgium, Colombia, France, Germany, Israel, Italy, Japan, Lebanon, Mexico, the Netherlands, New Zealand, Nigeria, People''s Republic of China (Beijing and Shanghai), Spain, and the United States. The WHO Composite International Diagnostic Interview (CIDI) was used to assess lifetime DSM-IV anxiety, mood, and substance use disorders. Ages of onset for individual disorders and ages of first treatment contact for each disorder were used to calculate the extent of failure and delay in initial help seeking. The proportion of lifetime cases making treatment contact in the year of disorder onset ranged from 0.8 to 36.4% for anxiety disorders, from 6.0 to 52.1% for mood disorders, and from 0.9 to 18.6% for substance use disorders. By 50 years, the proportion of lifetime cases making treatment contact ranged from 15.2 to 95.0% for anxiety disorders, from 7.9 to 98.6% for mood disorders, and from 19.8 to 86.1% for substance use disorders. Median delays among cases eventually making contact ranged from 3.0 to 30.0 years for anxiety disorders, from 1.0 to 14.0 years for mood disorders, and from 6.0 to 18.0 years for substance use disorders. Failure and delays in treatment seeking were generally greater in developing countries, older cohorts, men, and cases with earlier ages of onset. These results show that failure and delays in initial help seeking are pervasive problems worldwide. Interventions to ensure prompt initial treatment contacts are needed to reduce the global burdens and hazards of untreated mental disorders.     

获取复配农药最佳增效配方的一种简易方法

借鉴共毒因子法评价农药复配联合作用的思想,将参与复配的单剂引起25％死亡率的剂量定为零水平,利用二次回归通用旋转组合设计安排实验研究氯氰菊酯和喹硫磷复配对斜纹夜蛾（Spodoptera litura）2龄幼虫的增效作用,得出杀虫剂使用量与斜纹夜蛾幼虫死亡率机率值之间的关系,从共毒系数（CTC）的计算公式推导出共毒系数与杀虫混剂中两单剂使用浓度N1、N2之间的数学关系,CTC＝100／N1／α N2/b（α、b分别为氯氰菊酯和喹硫磷的LC50）,进而确定最优化问题的目标函数j=N1/α＋N2／b,利用国际统计分析软件SAS的NLP过程求最大共毒系数和最优配方,所得结论与共毒系数法一致。     

关于茭白黑粉菌的正名问题

茭白黑粉菌在文献中出现Yenia esculenta(P.Henn.)Liou及Ustilago esculenta P.Henn.两个名字。现经形态发生学的研究以明确新名字是否有效。此菌冬孢子没有休眠期,孢子成熟后在适宜的环境中即可萌发。萌发的最适pH值为6;最适温度为25％;不需要外界光的诱导,在黑暗条件下也能正常萌发;培养基中的营养成份对孢子萌发的速率有一定影响。冬孢子在不同的环境条件下,其萌发形态及方式都是稳定的:孢子萌发时产生有隔的担子或先菌丝(promycelium)。该先菌丝起初可以是无隔的,但生长到一定程度,便产生分隔,分隔多为2—4个。初生的先菌丝和小孢子是单核的,但成熟的先菌丝、小孢子及短菌丝细胞内均是双核的。可以认为,该菌的双核期在整个生活史中占有相当长的时间,它只有短暂的单核期。没有发现先菌丝、小孢子彼此之间或相互间融合的现象;未见到双核的融合及减数分裂过程。茭白黑粉菌在人工组合培养基上生成厚壁的孢子,较自然界中的冬孢子为大,但萌发方式则相同。最后作者等认为茭白黑粉菌仍应保留在Ustilago属中,而Yenia esculenta(P.Henn.)Liou的名字是无效的。     

Community mental health care in the Asia‐Pacific region: using current best‐practice models to inform future policy

The reporting of child sexual abuse (CSA) and physician-patient sexual relationships (PPSR) are currently the focus of professional, legal and media attention in several countries. This paper briefly reviews mental health policies on these issues and reports on a WPA survey of them. While the WPA Madrid Declaration permits breaching confidentiality for mandatory reporting of CSA and clearly prohibits PPSR, it is not known how or to what extent these policies are implemented in WPA Member Societies’ countries. It is also not known whether policies or laws exist on these topics nationally or to what extent psychiatrists and the public are aware of them. Representatives of WPA Member Societies were e-mailed a survey about issues pertaining to CSA and PPSR. Fifty-one percent of 109 countries replied. All reporting countries had laws or policies regarding the reporting of CSA, but this was often voluntary (63%) and without protection for reporting psychiatrists either by law (29%) or by Member Societies (27%). A substantial number of psychiatric leaders did not know the law (27%) or their Society’s policy (11%) on these matters. With respect to PPSR, some reporting countries lacked laws or policies about PPSR with current (17%) or past (56%) patients. Fewer than half of responding representatives believed that their Society’s members or the public were well informed about the laws and policies pertaining to CSA or PPSR. There is clearly a wide range of laws, policies and practices about CSA and PPSR in WPA Member Societies’ countries. There is a need in some countries for laws or supplemental policies to facilitate the protection of vulnerable child and adult patients through clear, mandatory reporting policies for CSA and PPSR. Mechanisms to protect and support reporting psychiatrists should also be developed where they do not already exist. There is also a need in some countries to develop strategies to improve the education of psychiatrists, trainees, and the public on these issues.The Asia-Pacific region has close to half of the estimated 450 million people affected by mental illness globally 1.Based on international mental health care benchmarks, many Western health systems have established contemporary health policy and guidelines which include the provision of mental health care in the community. However, the delivery of quality and appropriate community mental health care remains an ongoing challenge for countries of both high and low socio-economic level. Difficulties and obstacles in implementation of comprehensive community service models include inadequate funding, availability of trained mental health workforce, integration with primary care services and community agencies, and collaboration between public and private health systems 2 - 3. As community mental health service system depends on sufficient workforce for service delivery, the critical shortage of adequately trained mental health staff continues to impede the progress of mental health reform.In response to such global trends, many countries in the Asia-Pacific region have begun to establish mental health policy and guidelines to move from institutional care to community mental health services. While these reforms are supported by recommendations from the World Health Organization (WHO) governing bodies, such as the Western Pacific Regional Mental Health Strategy 4, social, economic and cultural factors in Asia-Pacific countries often do not allow ready translation of Western community mental health models of care. Governments and service providers commonly face challenges in the development and implementation of locally appropriate community mental health care and services. Additionally, it would be unrealistic or undesirable to produce rigid recommendations for a singular community mental health care model, due to the diversity across the Asia-Pacific region. Hence, for constructive change to occur in the region, innovative, culturally appropriate and economically sustainable pathways for community treatment models need to be explored, developed and shared. Community mental health service reform appears to be gaining momentum in this region, despite the obstacles. Valuable lessons and inspiration for further development can be gained from both the successes and difficulties in reforming mental health systems and practices in the region.An emerging network of representatives from governments, peak bodies and key organizations is emerging in the Asia-Pacific region to build supportive relationships in order to facilitate the implementation of locally appropriate policy frameworks for community mental health service reform. The network is supported by the Asia-Pacific Community Mental Health Development (APCMHD) project, which involves 14 countries/regions in the Asia-Pacific region. Initiated in collaboration with the WHO Western Pacific Regional Office, the APCMHD project is led by Asia-Australia Mental Health, a consortium of the University of Melbourne Department of Psychiatry and Asialink, and St. Vincent’s Health, which is a part of the WHO Collaborating Centre for Mental Health (Melbourne). The project, which brought many key mental health organizations to work collaboratively, is consistent with the WHO Global Action Programme for Mental Health 5.The project aims are to promote best practice in community mental health care through exchange of knowledge and practical experience in the Asia-Pacific region. The key outcome is the documentation of the current status, strengths and needs of community mental health services in the region, in the hope to translate current understanding into practical changes in the future.     

楝科物质对亚洲玉米螟幼虫取食和生长发育的影响

近年来植物成分对昆虫行为和生长发育的影响很受人们重视。对印楝(Azadirachta indica)的研究证明其含有多种杀虫物质(Schmutterer和Ascher等,1981)。国外报道与印楝为近缘种的苦楝(Melia azadirach)也对昆虫有拒食和干扰生长发育的作用(Schmutterer,1981;Tu和Rueda等,1981),并从中分离出了多种活性物质(Cox,1981)。我国也曾研究应用苦楝防治害虫(中国土农药志编辑委员会,1959),最近证明川楝(Melia toosendan)中成分对水稻三化螟有内吸致毒和拒食作用(赵善欢和张     

楝科植物油及种核粉抽提物对稻瘿蚊产卵忌避作用及防治试验

稻瘿蚊Orseolia oryzae发生世代亟叠,复杂,为害严重,是我国华南地区及东南亚水稻产区的重要害虫。近几年来,我们应用楝科等杀虫植物进行了防治试验,本文主要报道楝科种子油及其抽提物引起产卵稻瘿蚊忌避反应及防治效果。     

两种光敏化合物对斜纹夜蛾超氧物歧化酶影响的比较研究(英文)

室内测试了斜纹夜蛾Ｓｐｏｄｏｐｔｅｒａ ｌｉｔｕｒａ Ｆ． ４龄幼虫超氧物歧化酶的活性,并就α－三噻吩（α－ｔｅｒｔｈｉｅｎｙｌ）和化合物５,即１－苯基－４－（３,４－亚甲基二氧）苯基－丁二炔等两种光敏化合物对其产生的影响进行了比较研究。结果表明,近紫外光照（３００－４００ｎｍ）基本不影响对照幼虫超氧物歧化酶活体（ｉｎｖｉｖｏ）活力,但对其离休（ｉｎ ｖｉｔｒｏ）活力有抑制作用。经光敏化合物处理后,在紫外光照下,超氧物歧化酶活体活力基本不受化合物５的影响,但能被α－三噻吩抑制。离体情况下,两种化合物均促进其活力,α－三噻吩尤甚。表明无论在离体还是活体情况下,幼虫对α－三噻吩均比化合物５具有更高的光敏性。对两种光敏化合物可能的作用机理进行了探讨。     

外生菌根的形态学、解剖学及分类学研究进展

本文综述了外生菌根的形态学和解剖学特征,评价了这些特征用于外生菌根分类的价值,同时指出各种类型的形态学特征和解剖学特征与其营养吸收的关系。这些特征包括了菌根的颜色类型及变化、形状及分枝方式、外伸菌丝的多少及特征、根状菌索有无及分化、菌核有无及特征、菌套内外表面的菌丝排列及分化,菌套的切面特征,丹宁层厚度及分化、哈氏网的菌丝排列及厚度等。较详细阐述了100多年来,人们为外生菌根分类所作出的种种努力,并对各种分类方式作了简单的评价。     

蛋白质组学技术及其在生物医学上的应用

蛋白质组学部分承用了创立于二十多年前的二维电泳技术。基于其高分辩能力 ,二维电泳主要用于分离和检测复杂混合物中的蛋白质。虽然没有获得更多的改进 ,但是二维电泳结合了通过质谱测定蛋白质的最新进展而成为蛋白质组学中的一项重要技术。随着人类基因组计划项目的完成及由此而产生的大量基因数据库和使用这些数据的生物信息技术 ,科学家们的下一个目标是解析生物体的完整蛋白质组 ,把蛋白质组学数据与基因组学数据关联起来并有机地结合而成为一项有力的工具以阐明病理学中的蛋白质功能、衰老的过程及发现新药目标蛋白质和疾病标识物等。文章综述了蛋白质组学技术的最新知识及其在生物医学研究中的潜在应用